ACOPF - The a2 Milk Company Limited
| Previous Close | 3.4820 |
| Open | 3.4820 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.4820 - 3.4820 |
| 52 Week Range | 2.7500 - 4.9100 |
| Volume | |
| Avg. Volume | 1,737 |
| Market Cap | 2.514B |
| Beta (5Y Monthly) | 0.01 |
| PE Ratio (TTM) | 29.02 |
| EPS (TTM) | 0.1200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Are Investors Undervaluing The a2 Milk Company Limited (NZSE:ATM) By 49%?
Key Insights a2 Milk's estimated fair value is NZ$11.35 based on 2 Stage Free Cash Flow to Equity a2 Milk is estimated...
- Simply Wall St.
Are The a2 Milk Company Limited's (NZSE:ATM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
a2 Milk (NZSE:ATM) has had a rough three months with its share price down 18%. However, stock prices are usually driven...
- Simply Wall St.
a2 Milk (NZSE:ATM) sheds NZ$435m, company earnings and investor returns have been trending downwards for past three years
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
- Simply Wall St.
The a2 Milk Company Limited's (NZSE:ATM) market cap touched NZ$5.2b last week, benefiting both individual investors who own 51% as well as institutions
To get a sense of who is truly in control of The a2 Milk Company Limited ( NZSE:ATM ), it is important to understand...
- Simply Wall St.
Trade Alert: The Independent Non-Executive Director Of The a2 Milk Company Limited (NZSE:ATM), Philippa Greenwood, Has Just Spent NZ$198k Buying A Few More Shares
Investors who take an interest in The a2 Milk Company Limited ( NZSE:ATM ) should definitely note that the Independent...
- Simply Wall St.
The a2 Milk Company Limited's (NZSE:ATM) Intrinsic Value Is Potentially 48% Above Its Share Price
Does the December share price for The a2 Milk Company Limited ( NZSE:ATM ) reflect what it's really worth? Today, we...
- Simply Wall St.
Has The a2 Milk Company Limited (NZSE:ATM) Stock's Recent Performance Got Anything to Do With Its Financial Health?
a2 Milk's (NZSE:ATM) stock is up by 5.7% over the past three months. As most would know, long-term fundamentals have a...
- Reuters
UPDATE 1-NZ's a2 Milk gets temporary approval to export infant milk formula to U.S.
New Zealand's a2 Milk Co Ltd has received U.S. approval to export its infant milk formula to the Unites States as the country faces a shortage of baby food. Under the approval from the U.S. Food and Drug Administration (FDA), the dairy major will be able to sell and distribute its a2 Platinum infant milk formula product through to Jan. 6, 2023, the company said on Thursday. The move will help plug a gap in baby food supply in the United States after Abbott Laboratories, the biggest U.S. supplier of powder infant formula, in February recalled dozens of products after reports of serious bacterial infections in four infants.
- Simply Wall St.
Investors in a2 Milk (NZSE:ATM) have unfortunately lost 54% over the last three years
While not a mind-blowing move, it is good to see that the The a2 Milk Company Limited ( NZSE:ATM ) share price has...
- Simply Wall St.
a2 Milk (NZSE:ATM) Could Easily Take On More Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- Thomson Reuters StreetEvents
Edited Transcript of ATM.NZ earnings conference call or presentation 29-Aug-22 10:59am GMT
Full Year 2022 A2 Milk Company Ltd Earnings Call
- Reuters
UPDATE 1-NZ's a2 Milk says FDA deferred request to supply baby formula
New Zealand's A2 Milk Company Ltd said on Wednesday the U.S. Food and Drug Administration had deferred the dairy producer's request for an enforcement discretion to import infant milk formula products into the United States. A2 said it was informed by the International Dairy Foods Association that pending enforcement discretion applicants have also received similar communication from the FDA, indicating that the regulator is deferring any further review of all such applications at this time. Earlier this month, a2 dismissed a report suggesting that it was close to winning approval to sell baby formula in the United States, adding that the application was still under active review.
ReutersA2 Milk jumps before halt on FDA nod news, denies report
The company had in May confirmed an application to the U.S. Food and Drug Administration (FDA) seeking permission to supply baby food to the country. A2 Milk's stock price shot up as much as 12.2% to NZ$5.60 to hit its highest level since April 5. The media report suggested that FDA approval could be received "as soon as this week."
- Simply Wall St.
How Many The a2 Milk Company Limited (NZSE:ATM) Shares Do Institutions Own?
A look at the shareholders of The a2 Milk Company Limited ( NZSE:ATM ) can tell us which group is most powerful. Large...
- Simply Wall St.
The a2 Milk Company Limited's (NZSE:ATM) Intrinsic Value Is Potentially 97% Above Its Share Price
In this article we are going to estimate the intrinsic value of The a2 Milk Company Limited ( NZSE:ATM ) by taking the...
ReutersAntipodean dairy firms eye baby food supply to U.S. after Bubs Australia nod
(Reuters) -Dairy companies in Australia and New Zealand are queueing to restock empty shelves in the United States with baby food, after the country recently relaxed its import policy to mitigate one of the biggest infant formula shortages in recent history. New Zealand's dairy giants Fonterra and a2 Milk, and privately-run Australian firm Bellamy's Organic confirmed on Monday they had submitted applications to the U.S. Food and Drug Administration (FDA) for supplying baby food to the country. This followed fellow Antipodean firm Bubs Australia inking a deal with the FDA to ship at least 1.25 million cans of its formula.
- Reuters
NZ's a2 Milk seeks to supply infant formula to U.S. after Bubs approval
New Zealand's a2 Milk Company said on Monday it had submitted an application to the U.S. Food and Drug Administration (FDA) to supply infant milk formula after Australian peer Bubs received the health agency's clearance last week. The Antipodean companies were looking to cash in on a relaxation of regulations around infant formula imports by the FDA earlier this month to mitigate one of the biggest baby food shortages in the United States in recent history. The crisis was triggered when Abbott Laboratories, the biggest U.S. supplier of powder infant formula including Similac, in February recalled dozens of products after reports of serious bacterial infections in four infants.
- Simply Wall St.
The a2 Milk Company Limited (NZSE:ATM) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
With its stock down 21% over the past three months, it is easy to disregard a2 Milk (NZSE:ATM). However, the company's...